Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide

K.A. van Nifterik, J. Berg, W.F. van der Meide, N. Ameziane, L.E. Wedekind, R.D.M. Steenbergen, S. Leenstra, M.V.M. Lafleur, B.J. Slotman, L.J.A. Stalpers, P. Sminia

Research output: Contribution to journalArticleAcademicpeer-review

60 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)29-35
JournalBritish Journal of Cancer
Volume103
Issue number1
DOIs
Publication statusPublished - 2010

Cite this

van Nifterik, K. A., Berg, J., van der Meide, W. F., Ameziane, N., Wedekind, L. E., Steenbergen, R. D. M., ... Sminia, P. (2010). Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide. British Journal of Cancer, 103(1), 29-35. https://doi.org/10.1038/sj.bjc.6605712